18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描最大标准化摄取值与葡萄糖转运蛋白-1 表达与胰腺浸润性导管癌的生存相关。

Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.

机构信息

From the Departments of *Surgery, †Internal Medicine (Division of Gastroenterology), ‡Hospital Pathology, and §Radiology, Kurume University School of Medicine, Kurume, Japan.

出版信息

Pancreas. 2014 Oct;43(7):1060-5. doi: 10.1097/MPA.0000000000000185.

Abstract

OBJECTIVES

The purpose of this study was to assess the correlations among the maximum standardized uptake value (SUVmax) on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography (FDG-PET/CT); the expressions of glucose transporter 1 (GLUT-1), glucose transporter 3, and epidermal growth factor receptor (EGFR); as well as prognosis in patients with invasive ductal carcinoma of the pancreas.

METHODS

A total of 41 patients with surgically resected and histologically proven invasive ductal carcinoma of the pancreas who underwent preoperative FDG-PET/CT were assessed. The SUVmax at the primary tumor site was measured by FDG-PET/CT, and immunohistochemical staining of tumor sections was performed for GLUT-1, glucose transporter 3, and EGFR.

RESULTS

Higher FDG uptake (SUVmax, >3.40) and GLUT-1 expression were significantly associated with shorter overall survival (P < 0.05). The SUVmax was not found to be significantly correlated with clinicopathological characteristics such as TNM classification, lymph node metastasis, and tumor differentiation. The EGFR expression was significantly correlated with the SUVmax (P = 0.024).

CONCLUSIONS

Higher FDG uptake and GLUT-1 expression in invasive ductal carcinoma of the pancreas seems to be an important prognostic factor. In addition, the EGFR expression was significantly correlated with the SUVmax.

摘要

目的

本研究旨在评估 18F-氟-2-脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)上的最大标准化摄取值(SUVmax);葡萄糖转运蛋白 1(GLUT-1)、葡萄糖转运蛋白 3 和表皮生长因子受体(EGFR)的表达;以及胰腺浸润性导管癌患者的预后之间的相关性。

方法

共评估了 41 例经手术切除和组织学证实的胰腺浸润性导管癌患者,这些患者均接受了术前 FDG-PET/CT 检查。通过 FDG-PET/CT 测量原发肿瘤部位的 SUVmax,并对肿瘤切片进行 GLUT-1、葡萄糖转运蛋白 3 和 EGFR 的免疫组织化学染色。

结果

较高的 FDG 摄取(SUVmax,>3.40)和 GLUT-1 表达与总生存期较短显著相关(P<0.05)。SUVmax 与 TNM 分类、淋巴结转移和肿瘤分化等临床病理特征无显著相关性。EGFR 表达与 SUVmax 显著相关(P=0.024)。

结论

胰腺浸润性导管癌中较高的 FDG 摄取和 GLUT-1 表达似乎是一个重要的预后因素。此外,EGFR 表达与 SUVmax 显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fd/4175014/5183782d1792/mpa-43-1060-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索